277 related articles for article (PubMed ID: 31301306)
21. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
Packenham JP; du Manoir S; Schrock E; Risinger JI; Dixon D; Denz DN; Evans JA; Berchuck A; Barrett JC; Devereux TR; Ried T
Mol Carcinog; 1997 Aug; 19(4):273-9. PubMed ID: 9290705
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up.
Mills AM; Ly A; Balzer BL; Hendrickson MR; Kempson RL; McKenney JK; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):634-42. PubMed ID: 23552380
[TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of progesterone receptor, epithelial growth factor receptor and galectin-3 in uterine smooth muscle tumors.
Soltan MM; Albasry AM; Eldosouky MK; Abdelhamid HS
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):7-12. PubMed ID: 29729689
[TBL] [Abstract][Full Text] [Related]
25. Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.
Mas A; Simón C
Biol Reprod; 2019 Dec; 101(6):1115-1123. PubMed ID: 30184111
[TBL] [Abstract][Full Text] [Related]
26. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.
Rubisz P; Ciebiera M; Hirnle L; Zgliczyńska M; Łoziński T; Dzięgiel P; Kobierzycki C
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845657
[TBL] [Abstract][Full Text] [Related]
27. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
Liegl-Atzwanger B; Heitzer E; Flicker K; Müller S; Ulz P; Saglam O; Tavassoli F; Devouassoux-Shisheboran M; Geigl J; Moinfar F
Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
[TBL] [Abstract][Full Text] [Related]
28. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
29. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM.
Braný D; Dvorská D; Grendár M; Ňachajová M; Szépe P; Lasabová Z; Žúbor P; Višňovský J; Halášová E
Pathol Res Pract; 2019 Aug; 215(8):152465. PubMed ID: 31176573
[TBL] [Abstract][Full Text] [Related]
30. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
31. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.
Chuang TD; Ho M; Khorram O
Reprod Sci; 2015 May; 22(5):563-71. PubMed ID: 25305131
[TBL] [Abstract][Full Text] [Related]
32. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
[TBL] [Abstract][Full Text] [Related]
33. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas.
Hall KL; Teneriello MG; Taylor RR; Lemon S; Ebina M; Linnoila RI; Norris JH; Park RC; Birrer MJ
Gynecol Oncol; 1997 May; 65(2):330-5. PubMed ID: 9159347
[TBL] [Abstract][Full Text] [Related]
35. STMN1 and MKI67 Are Upregulated in Uterine Leiomyosarcoma and Are Potential Biomarkers for its Diagnosis.
Hu X; Zhang H; Zheng X; Lin Z; Feng G; Chen Y; Pan Q; Ni F
Med Sci Monit; 2020 May; 26():e923749. PubMed ID: 32425177
[TBL] [Abstract][Full Text] [Related]
36. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.
Kim K; Kim S; Ahn T; Kim H; Shin SJ; Choi CH; Park S; Kim YB; No JH; Suh DH
BMC Cancer; 2023 Dec; 23(1):1215. PubMed ID: 38066476
[TBL] [Abstract][Full Text] [Related]
37. Profiling of differentially expressed genes in human uterine leiomyomas.
Lee EJ; Kong G; Lee SH; Rho SB; Park CS; Kim BG; Bae DS; Kavanagh JJ; Lee JH
Int J Gynecol Cancer; 2005; 15(1):146-54. PubMed ID: 15670310
[TBL] [Abstract][Full Text] [Related]
38. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.
Momeni M; Kalir T; Farag S; Kinoshita Y; Roman TY; Chuang L; Fishman DA; Burstein DE
Reprod Sci; 2014 Sep; 21(9):1171-6. PubMed ID: 24784718
[TBL] [Abstract][Full Text] [Related]
40. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
